Biogen | BIIB - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
AbbVie USD 72M 13M 2026-03
Acadia Pharmaceuticals USD 8.06M 277K 2026-03
ALKERMES USD 8.54M 3.59M 2026-03
Bayer EUR 169M 39M 2025-12
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 95M 0 2026-03
Incyte USD 38.12M 4.43M 2026-06
Merck USD 35M 34M 2026-03
Moderna USD 72M 2M 2026-03
Pfizer USD -0.04 115M 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sanofi EUR 77M 17M 2026-06
Sanofi EUR 60M 54M 2026-03
Sarepta Therapeutics USD 7M 1.74M 2026-03
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
United Therapeutics USD 31.5M 10.3M 2026-06
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06